State Ledger
Company profile

Immunome Inc. CIK 1472012

Ticker
IMNM (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Bothell, WA 98011
Fiscal year end
2025 (FY)
Market Data
Close
$19.56
Change
+$0.24
Change %
1.24%
Volume
78,335

IMNM · trading date Oct 9, 2026 · previous close $19.32 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$6.94M
Net income
-$212.39M
Total assets
$683.19M
Total liabilities
$48.85M
Stockholders' equity
$634.34M
Cash & equivalents
$653.48M
Operating income
-$224.11M
Operating cash flow
-$190.92M
Capital expenditures
$9.69M

Fiscal year 2025, via 10-K filed 2026-03-03. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-3,228.8%
Net margin
-3,060.0%
Free cash flow
-$200.60M
Free cash flow margin
-2,890.1%
Liabilities / assets
7.1%
Equity / assets
92.9%
CapEx / revenue
139.5%
Operating cash flow / net income
0.90×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $6.94M -$212.39M $683.19M $48.85M $634.34M
2024 $9.04M -$292.96M $240.24M $59.08M $181.17M
2023 $14.02M -$106.81M $148.54M $28.66M $119.88M
2022 — -$36.90M $24.05M $7.39M $16.65M
2021 — -$24.71M $57.93M $9.74M $48.19M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-15
Financials filed via
Form 10-K
filed 2026-03-03

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Bothell, WA 98011
18702 N. CREEK PARKWAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:01 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Washington — Public Companies